mitiglinide has been researched along with insulin glargine in 4 studies
| Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) | Studies (insulin glargine) | Trials (insulin glargine) | Recent Studies (post-2010) (insulin glargine) |
|---|---|---|---|---|---|
| 120 | 30 | 50 | 2,184 | 772 | 1,350 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Hara, K; Hirose, T; Kanazawa, A; Kanazawa, Y; Kanno, R; Kawai, J; Kawamori, R; Kumashiro, N; Mita, T; Miwa, S; Motojima, K; Sakai, K; Sakurai, Y; Sato, F; Shimizu, T; Tanaka, Y; Uchino, H; Watada, H; Yamazaki, Y; Yoshihara, T | 1 |
| Fujitani, Y; Hirose, T; Kanazawa, Y; Kawamori, R; Kumashiro, N; Shimizu, T; Tanaka, Y; Watada, H; Yoshihara, T | 1 |
| Kato, T; Matsuda, Y; Murakami, T; Muro, S; Nambu, T; Oki, S; Yonemitsu, S | 1 |
| Baik, SH; Cha, BS; Jang, HC; Lee, IK; Lee, KW; Park, TS; Son, JW; Sung, YA; Woo, JT; Yoo, SJ; Yoon, KH | 1 |
4 trial(s) available for mitiglinide and insulin glargine
| Article | Year |
|---|---|
Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Aspart; Insulin Glargine; Insulin, Long-Acting; Isoindoles; Male; Middle Aged; Postprandial Period; Time Factors | 2006 |
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study.
Topics: Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Glargine; Insulin, Long-Acting; Isoindoles; Male; Middle Aged; Research Design; Time; Time Factors; Treatment Outcome | 2007 |
Add-on treatment with mitiglinide improves residual postprandial hyperglycemia in type 2 diabetic patients receiving the combination therapy with insulin glargine and sitagliptin.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Humans; Hyperglycemia; Insulin Glargine; Isoindoles; Male; Monitoring, Physiologic; Sitagliptin Phosphate | 2015 |
A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Insulin Glargine; Isoindoles; Male; Middle Aged; Prospective Studies | 2015 |